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ABSTRACT
The authors report a case of a 29-year-old male patient
with a severe lower gastrointestinal hemorrhage in whom
a successful laparoscopic diagnosis and resection (assist-
ed) of an ileal gastrointestinal stromal tumor (GIST) was
performed. Laparoscopy can be very useful in the diag-
nosis and treatment of selected cases of lower gastroin-
testinal bleeding.
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INTRODUCTION
The diagnosis of occult gastrointestinal bleeding of
obscure origin is one of the most vexing problems con-
fronting physicians.
1 Despite impressive technological
advances during the last 30 years, the management of
bleeding from the lower gastrointestinal tract remains a
diagnostic and therapeutic challenge. Although a gener-
ally accepted treatment protocol for upper gastrointesti-
nal tract hemorrhage has been established, there is no
similar consensus for the management of hemorrhage
originating distal to the Treitz ligament.
2
CASE REPORT
A 29-year-old white male was seen in the emergency
room of the American-British Hospital of Mexico City,
referred from a rural clinic in one of the neighbor states
of Mexico City with a 4-day history of severe gastroin-
testinal bleeding characterized at first by melena and
then hematochezia. Six units of packed red blood cells
were transfused to the patient before his admission to the
emergency room. Past history was unrewarding except
for a laparoscopic fundoplication nine months before for
severe gastroesophageal reflux disease. Clinical exami-
nation revealed generalized pallor and red blood on rec-
tal digital exam. Blood pressure was 100/60 mm Hg with
a pulse of 90 beats per minute. A complete blood count
demonstrated a hemoglobin of 8.6 mg/1. An emergency
esophagogastroduodenoscopy was negative for bleeding
and showed a properly functioning fundoplication; a
colonoscopy performed two hours later after bowel
preparation showed fresh blood in the large bowel com-
ing from the ileum. The next morning the patient was
taken to the operating room, and, under general anes-
thesia, a 10 mm trocar was placed in the umbilicus. The
abdominal cavity was inspected and immediately a 6 x 5
cm ileal cystic dark mass was identified in the pelvic area
(Figure 1). Another 10 mm trocar was placed in the
right flank and a 5 mm one in the left flank. The whole
small bowel was inspected from the ligament of Treitz to
the ileocecal valve and the tumor was located at 50 cm
proximal to the latter. The umbilical incision was
extended 3 cm downwards, the wound protected, the
tumor exteriorized (Figure 2), and a 20 cm ileal resec-
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Figure 1. The cystic mass is identified in the small bowel.
tion was performed, followed by a termino-terminal sta-
pler anastomosis. The postoperative course was
uneventful: a liquid diet was tolerated the following day,
a normal bowel movement occurred on postoperative
day 2, and the patient was discharged on postoperative
day 4 and remains asymptomatic 18 months later.
PATHOLOGICAL EXAMINATION
The specimen was a segment of small intestine which
measured 17 x 2.5 cm. On its outer surface, a neoplasm
was identified pending from the antimesenteric border. It
had a reddish-brown hue, bosselated surface with areas
of recent hemorrhage and measured 6 x 5.5 x 4 cm. On
sectioning, it had a firm consistency, and the surface was
trabeculated, gray-pink and with focal hemorrhage at the
periphery. The base of implantation was 3 cm wide, and
part of the neoplasia protruded through the bowel wall,
creating a dumbbell shape (Figure 3). This was associ-
ated with an extensive ulcer overlying the mucosa.
Microscopically, the tumor was hypercellular and made
up of bundles of fusiform cells with bland nuclei, homo-
geneous chromatin pattern, occasional small, inconspicu-
ous and usually single nucleolus. The cytoplasm was
eosinophilic and homogeneous with unapparent cell bor-
ders. There were 2 mitotic figures in a 150 hpf count, no
necrotic foci, no pleomorphic cells nor "skeinoid" fibers,
and only scattered hemorrhagic areas (Figure 4). The
immunohistochemical profile showed focal positivity for
ps-100, CD34 (QBENd/10); actin antigen (PCNA) was
strongly positive in 4.1% of neoplastic cells. DNA analy-
Figure 2. Exteriorized tumor.
sis (CAS-200) showed a hypodiploid population (DNA
index: 0.4, s-phase: 3.3).
Final Pathological Diagnosis
Low risk small bowel stromal tumor (GIST), based on
size (6 x 5.5 cm), no necrosis, 2 mitotic figures in hpfs
and PCNA index lower than 10%.
DISCUSSION
Etiology of acute lower gastrointestinal bleeding is close-
ly associated with the patient's age. In adolescents and
young adults, Meckel's diverticulum, inflammatory bowel
disease and polyps account for the majority of cases. In
adult patients up to 60 years of age, diverticulosis,
inflammatory bowel disease, and polyps are the most
common cause, whereas in patients older than 60 years
angiodysplasia, diverticulosis and cancer are the most
common etiologies. Most acute lower gastrointestinal
bleeding episodes arise from the colon; however, 15% to
20% originate in the small intestine.
2,
3 It must be men-
tioned that the yield of small bowel series performed to
evaluate patients with obscure gastrointestinal bleeding
is 2% to 3% for small bowel tumors; use of enteroclysis,
or double-contrast small bowel series, may increase the
yield 6% to 10%. "Push enteroscopy" should be the next
step in the evaluation of all cases of gastrointestinal
bleeding of obscure origin because diagnostic yield has
been reported to be that of 5% to 20% for small bowel
masses. Intraoperative enteroscopy increases diagnostic
yield by 20% to 30%.
1 Other tests such as CT scan and
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Figure 3. Macroscopic appearance of the tumor.
endoscopic ultrasound have occasionally showed good
results.
3 In this case, the colonoscopy was of great
importance because it gave us the information that the
bleeding site was located within the limits of the jejunum
and the ileum.
Following the endoscopic procedures, it was decided
that the patient should be explored in the operative room
given the negligible morbidity of a diagnostic
laparoscopy. The rationale was that arteriography has a
relatively high complication rate (up to 9%) that includes
arterial thrombosis, embolization, and renal failure and
success rates vary widely (14% to 72%); that radionuclide
scanning is time consuming, and several reports in the
literature are not encouraging
3; that the bleeding site was
located somewhere between the proximal jejunum and
the ileum and given the patient's age the likelihood of an
etiologic factor that could be readily identified by
laparoscopy. Provisions were made to perform an intra-
operative enteroscopy if the need was present.
Primary benign and malignant as well as metastatic neo-
plasms of the small bowel are rare entities, comprising
less than 5% of all gastrointestinal tumors and 0.35% of
all malignancies.
1 Gastrointestinal stromal tumors
(GISTs) have been the subject of considerable debate
since their earliest descriptions, with controversy center-
ing on the cell of origin, line of cellular differentiation
and the prediction of clinical behavior.
4-
6 It is hard to
estimate the exact incidence of GIST from previous
reports in the literature.
5 Both benign and malignant
Figure 4. Microscopic appearance of the mass.
stromal tumors may occur at any age and either sex.
7
Whereas most of them are asymptomatic, the most com-
mon presenting symptom is gastrointestinal bleeding;
other manifestations are obstruction, intussusception or,
rarely, perforation.
1,5,
7 Despite advances in technology,
preoperative diagnosis of GIST — specially of those in the
small bowel — is often difficult and usually requires
laparotomy.
8 Most of these tumors are located in the
stomach (47%), small bowel and rectum (11%), colon
(7%), duodenum (5%) and esophagus (5%).
9 Both
benign and malignant tumors can share a similar appear-
ance, even when the latter tend to be bigger than the
former. From a microscopic standpoint, these neoplasms
have a wide variation regarding growth patterns. There
is not, however, a single immunohistochemical profile
that allows one to predict the neoplasm's biological
behavior. Generally accepted malignancy criteria include
a diameter of more than 5 cm, invasion to nearby struc-
tures, necrosis, hypercellularity, increased nucleus/cyto-
plasm ratio, mitotic rate greater than 1-5 per 10 hpf, and
infiltration of the overlying mucosa.
5 Sometimes, the
term "uncertain biological conduct" should be adopted.
In these cases, evaluation of proliferative activity by
immunohistochemical methods appears to be promising,
though inconstant.
4,10,1
2 The greatest value of tests using
proliferative markers is the possibility to re-classify with
more precision tumors that were considered as "border-
line" or of "unknown biological conduct" into high or
low-risk groups. Most common sites of metastasis are
the liver and the peritoneum.
13,1
4 Lymph nodes are
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affected in 7%-10% of cases, and rarely are extra-abdom-
inal structures invaded: lung, subcutaneous tissue, brain,
thyroid, bone, kidney, adrenals, heart, larynx, skin and
spermatic cord.
5 As GISTs are usually radio-resistant and
insensitive to chemotherapeutic agents, the only curative
therapy is surgical excision.
8
It is likely that this tumor was present during the previ-
ous laparoscopic surgery, but a careful review of the
video a posteriori did not reveal any abnormality during
the abdominal inspection (although an examination of
the small bowel was not done), and the patient did not
have any evidence of anemia and/or any other gastroin-
testinal symptoms.
Laparoscopic surgery for small bowel obstruction, perfo-
rated diverticulitis, and for benign and malignant tumors
of the small and large intestine has produced excellent
results in experienced hands, although in some cases
may require conversion to laparotomy and/or an assisted
procedure.
15-1
8 In the case herein presented, the tumor
was localized immediately with the aid of a simple diag-
nostic laparoscopy, which allowed a successful assisted
resection.
CONCLUSION
New applications of minimally invasive surgery are con-
tinuously being described. It is recommended that in
some selected, well-evaluated patients with lower gas-
trointestinal bleeding of unknown origin and stable vital
signs, laparoscopy may provide a precise diagnosis and
adequate treatment within the same procedure, avoiding
the need for time-consuming studies with substantial
morbidity and expense.
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